Rose, A.von Spee-Mayer, C.Kloke, LutzWu, K.Enghard, P.Kühl, A.Humrich, J.Y.Riemekasten, G.2018-07-232018-07-232016-112452-1981https://depositonce.tu-berlin.de/handle/11303/8032http://dx.doi.org/10.14279/depositonce-7196en610 Medizin und GesundheitT cellsIL-2 therapyCD4+P45 IL-2 therapy reduces renal inflammation and cellular activity of intrarenal CD4+ conventional T cells in lupus prone mice with active lupus nephritisArticle